WASHINGTON, D.C. (Friday, February 15, 2008) - The Biotechnology Industry Organization (BIO) welcomed over 2,000 biotechnology executives and investors to its tenth annual BIO CEO & Investor Conference.
“Despite unsettled markets in the first part of this year, the record number of investors shows the continued strong interest in the biotech space, “ said BIO President and CEO Jim Greenwood. “The continued success of this event demonstrates the importance of gathering industry executives and investors together to learn about the upcoming investment trends and opportunities which will contribute to future innovation and success in our industry.”
This year’s conference featured six roundtable sessions, corporate presentations from more than 200 hundred companies (approximately 80% public, 20% late-stage private), ten therapeutic workshops, plenary sessions on business issues and industry trends, and numerous networking opportunities. In addition, more than 1,300 one-on-one meetings took place at the conference, which was held at the Waldorf=Astoria Hotel in New York City, February 11-13.
Top therapeutic categories represented at the event included cancer, CNS, infections, cardiovascular/circulatory, and auto-immune disorders, represented by companies from 17 US states and 10 countries. The average marketing cap for presenting publically-traded companies is $435M, with a median market cap of $139M.
The BIO CEO & Investor Conference provides a forum for public and private equity investors, research analysts, investment bankers and senior-level industry executives to learn about and discuss investment trends and business development opportunities in the biotechnology industry.
To learn more about BIO and other upcoming events, please visit www.bio.org.
Upcoming BIO Events
· Partnering for Global Health
March 10-12, 2008
· BIO-Europe Spring
April 7-9, 2008
· BIO National Venture Conference
April 22-23, 2008
· World Congress on Industrial Biotechnology & Bioprocessing
April 27-30, 2008
· 2008 BIO International Convention
June 17-20, 2008
San Diego, Calif.
<?xml:namespace prefix = o />
BIO represents more than 1,150 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.